I am a lifelong non-smoker, and I credits medical advancements for allowing me to keep the disease at bay. I am currently benefiting from a targeted therapy drug called Alectinib, one of a new class of treatments made possible through breakthroughs in biomarker and genetic testing.

I’m fortunate that there’s been no progression, as science has given me more time, and I give back however I can, with the help and care of my wife, Robyn.

Our fundraising goal is $1,000.00 and dedicated to improving survival rates, supporting patients and advancing research.

Lung cancer remains the leading cause of cancer death in the United States, accounting for about one in five cancer deaths, according to the American Cancer Society. Each year, it kills more people than colon, breast and prostate cancers combined. Despite its impact, lung cancer research continues to receive far less federal funding compared to other cancers.